ReP USP - Resultado da busca

Artigo de periodico
Chronic kidney disease in patients with childhood-onset systemic lupus erythematosus (2023)
Sakamoto, Ana Paula ; Silva, Clovis Artur Almeida da ; Islabao, Aline Garcia ; Novak, Glaucia Vanessa; Molinari, Beatriz C; Nogueira, Paulo César Koch ; Pereira, Rosa Maria Rodrigues ; Magalhães, Claudia Saad ; Clemente, Gleice ; Piotto, Daniela Gerent Petry ; Carvalho, Luciana Martins de ; Bonfa, Eloisa Silva Dutra de Oliveira
Source: Pediatric nephrology. Unidades: FMRP, FM
Subjects: NEFRITE, INSUFICIÊNCIA RENAL CRÔNICA, LÚPUS ERITEMATOSO CUTÂNEO, ADOLESCENTES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SAKAMOTO, Ana Paula et al. Chronic kidney disease in patients with childhood-onset systemic lupus erythematosus. Pediatric nephrology, v. 38, n. 6, p. 1843-1854, 2023Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/53996. Acesso em: 29 jun. 2024.
APA
Sakamoto, A. P., Silva, C. A. A. da, Islabao, A. G., Novak, G. V., Molinari, B. C., Nogueira, P. C. K., et al. (2023). Chronic kidney disease in patients with childhood-onset systemic lupus erythematosus. Pediatric nephrology, 38( 6), 1843-1854. doi:10.1007/s00467-022-05811-y
NLM
Sakamoto AP, Silva CAA da, Islabao AG, Novak GV, Molinari BC, Nogueira PCK, Pereira RMR, Magalhães CS, Clemente G, Piotto DGP, Carvalho LM de, Bonfa ESD de O. Chronic kidney disease in patients with childhood-onset systemic lupus erythematosus [Internet]. Pediatric nephrology. 2023 ; 38( 6): 1843-1854.[citado 2024 jun. 29 ] Available from: https://observatorio.fm.usp.br/handle/OPI/53996
Vancouver
Sakamoto AP, Silva CAA da, Islabao AG, Novak GV, Molinari BC, Nogueira PCK, Pereira RMR, Magalhães CS, Clemente G, Piotto DGP, Carvalho LM de, Bonfa ESD de O. Chronic kidney disease in patients with childhood-onset systemic lupus erythematosus [Internet]. Pediatric nephrology. 2023 ; 38( 6): 1843-1854.[citado 2024 jun. 29 ] Available from: https://observatorio.fm.usp.br/handle/OPI/53996
Artigo de periodico
Quality of life, fatigue, sleep quality, and mental health in systemic lupus erythematosus patients with a high cardiovascular risk profile (2023)
Mazzolani, Bruna Caruso ; Smaira, Fabiana Infante ; Sieczkowska, Sofia Mendes ; Romero, Marina; Ribeiro, Thaina Toledo; Amarante, Milla Cordeiro ; Pasoto, Sandra G ; Pinto, Ana Lúcia de Sá ; Lima, Fernanda Rodrigues; Benatti, Fabiana B ; Bonfa, Eloisa Silva Dutra de Oliveira ; Roschel, Hamilton ; Gualano, Bruno
Source: Lupus. Unidades: FM, EEFE, EE
Subjects: LÚPUS ERITEMATOSO SISTÊMICO, QUALIDADE DE VIDA, SAÚDE MENTAL, DOENÇAS CARDIOVASCULARES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MAZZOLANI, Bruna Caruso et al. Quality of life, fatigue, sleep quality, and mental health in systemic lupus erythematosus patients with a high cardiovascular risk profile. Lupus, v. 32, n. 11, p. 1287-1295, 2023Tradução . . Disponível em: https://doi.org/10.1177/096120332312025. Acesso em: 29 jun. 2024.
APA
Mazzolani, B. C., Smaira, F. I., Sieczkowska, S. M., Romero, M., Ribeiro, T. T., Amarante, M. C., et al. (2023). Quality of life, fatigue, sleep quality, and mental health in systemic lupus erythematosus patients with a high cardiovascular risk profile. Lupus, 32( 11), 1287-1295. doi:10.1177/09612033231202582
NLM
Mazzolani BC, Smaira FI, Sieczkowska SM, Romero M, Ribeiro TT, Amarante MC, Pasoto SG, Pinto AL de S, Lima FR, Benatti FB, Bonfa ESD de O, Roschel H, Gualano B. Quality of life, fatigue, sleep quality, and mental health in systemic lupus erythematosus patients with a high cardiovascular risk profile [Internet]. Lupus. 2023 ; 32( 11): 1287-1295.[citado 2024 jun. 29 ] Available from: https://doi.org/10.1177/096120332312025
Vancouver
Mazzolani BC, Smaira FI, Sieczkowska SM, Romero M, Ribeiro TT, Amarante MC, Pasoto SG, Pinto AL de S, Lima FR, Benatti FB, Bonfa ESD de O, Roschel H, Gualano B. Quality of life, fatigue, sleep quality, and mental health in systemic lupus erythematosus patients with a high cardiovascular risk profile [Internet]. Lupus. 2023 ; 32( 11): 1287-1295.[citado 2024 jun. 29 ] Available from: https://doi.org/10.1177/096120332312025
Artigo de periodico
Interaction of TNFi and conventional synthetic DMARD in SARS-CoV-2 vaccine response in axial spondyloarthritis and psoriatic arthritis (2023)
Saad, Carla G. S; Silva, Matheus S. R; Sampaio-Barros, Percival D; Moraes, Julio C. B; Schainberg, Claudia G; Goncalves, Celio R; Shimabuco, Andrea Y; Aikawa, Nadia E; Silva, Clovis Artur Almeida da ; Bonfa, Eloisa Silva Dutra de Oliveira
Source: Joint bone spine. Unidade: FM
Subjects: COVID-19, IMUNOGENICIDADE DA VACINA, DOENÇAS AUTOIMUNES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SAAD, Carla G. S et al. Interaction of TNFi and conventional synthetic DMARD in SARS-CoV-2 vaccine response in axial spondyloarthritis and psoriatic arthritis. Joint bone spine, v. 90, n. 1, 2023Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/50747. Acesso em: 29 jun. 2024.
APA
Saad, C. G. S., Silva, M. S. R., Sampaio-Barros, P. D., Moraes, J. C. B., Schainberg, C. G., Goncalves, C. R., et al. (2023). Interaction of TNFi and conventional synthetic DMARD in SARS-CoV-2 vaccine response in axial spondyloarthritis and psoriatic arthritis. Joint bone spine, 90( 1). doi:10.1016/j.jbspin.2022.105464
NLM
Saad CGS, Silva MSR, Sampaio-Barros PD, Moraes JCB, Schainberg CG, Goncalves CR, Shimabuco AY, Aikawa NE, Silva CAA da, Bonfa ESD de O. Interaction of TNFi and conventional synthetic DMARD in SARS-CoV-2 vaccine response in axial spondyloarthritis and psoriatic arthritis [Internet]. Joint bone spine. 2023 ; 90( 1):[citado 2024 jun. 29 ] Available from: https://observatorio.fm.usp.br/handle/OPI/50747
Vancouver
Saad CGS, Silva MSR, Sampaio-Barros PD, Moraes JCB, Schainberg CG, Goncalves CR, Shimabuco AY, Aikawa NE, Silva CAA da, Bonfa ESD de O. Interaction of TNFi and conventional synthetic DMARD in SARS-CoV-2 vaccine response in axial spondyloarthritis and psoriatic arthritis [Internet]. Joint bone spine. 2023 ; 90( 1):[citado 2024 jun. 29 ] Available from: https://observatorio.fm.usp.br/handle/OPI/50747
Artigo de periodico
Ocular retinal findings in asymptomatic patients with antiphospholipid syndrome secondary to systemic lupus erythematosus (2023)
Silva Neto, Epitacio Dias da ; Rodrigues Neto, Taurino dos Santos ; Signorelli, Flavio Victor; Balbi, Gustavo Guimaraes Moreira ; Higashi, Alex Haruo; Monteiro, Mario Luiz Ribeiro ; Bonfa, Eloisa Silva Dutra de Oliveira ; Andrade, Danieli Castro Oliveira de ; Zacharias, Leandro Cabral
Source: Clinical rheumatology. Unidade: FM
Subjects: RETINA, LÚPUS ERITEMATOSO SISTÊMICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA NETO, Epitacio Dias da et al. Ocular retinal findings in asymptomatic patients with antiphospholipid syndrome secondary to systemic lupus erythematosus. Clinical rheumatology, v. 42, n. 8, p. 2105-2114, 2023Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/54727. Acesso em: 29 jun. 2024.
APA
Silva Neto, E. D. da, Rodrigues Neto, T. dos S., Signorelli, F. V., Balbi, G. G. M., Higashi, A. H., Monteiro, M. L. R., et al. (2023). Ocular retinal findings in asymptomatic patients with antiphospholipid syndrome secondary to systemic lupus erythematosus. Clinical rheumatology, 42( 8), 2105-2114. doi:10.1007/s10067-023-06613-9
NLM
Silva Neto ED da, Rodrigues Neto T dos S, Signorelli FV, Balbi GGM, Higashi AH, Monteiro MLR, Bonfa ESD de O, Andrade DCO de, Zacharias LC. Ocular retinal findings in asymptomatic patients with antiphospholipid syndrome secondary to systemic lupus erythematosus [Internet]. Clinical rheumatology. 2023 ; 42( 8): 2105-2114.[citado 2024 jun. 29 ] Available from: https://observatorio.fm.usp.br/handle/OPI/54727
Vancouver
Silva Neto ED da, Rodrigues Neto T dos S, Signorelli FV, Balbi GGM, Higashi AH, Monteiro MLR, Bonfa ESD de O, Andrade DCO de, Zacharias LC. Ocular retinal findings in asymptomatic patients with antiphospholipid syndrome secondary to systemic lupus erythematosus [Internet]. Clinical rheumatology. 2023 ; 42( 8): 2105-2114.[citado 2024 jun. 29 ] Available from: https://observatorio.fm.usp.br/handle/OPI/54727
Artigo de periodico
Rosa Maria Rodrigues Pereira (1958-2022) IN MEMORIAM (2023)
Jorgetti, Vanda ; Barros, Percival Degrava Sampaio ; Shinjo, Samuel Katsuyuki ; Bonfa, Eloisa Silva Dutra de Oliveira
Source: Journal of bone and mineral research. Unidade: FM
Subjects: ARTIGOS DE PERIÓDICOS, BIOGRAFIAS, REUMATOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
JORGETTI, Vanda et al. Rosa Maria Rodrigues Pereira (1958-2022) IN MEMORIAM. Journal of bone and mineral research, v. 38, n. 3, p. 357-358, 2023Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/53836. Acesso em: 29 jun. 2024.
APA
Jorgetti, V., Barros, P. D. S., Shinjo, S. K., & Bonfa, E. S. D. de O. (2023). Rosa Maria Rodrigues Pereira (1958-2022) IN MEMORIAM. Journal of bone and mineral research, 38( 3), 357-358. doi:10.1002/jbmr.4767
NLM
Jorgetti V, Barros PDS, Shinjo SK, Bonfa ESD de O. Rosa Maria Rodrigues Pereira (1958-2022) IN MEMORIAM [Internet]. Journal of bone and mineral research. 2023 ; 38( 3): 357-358.[citado 2024 jun. 29 ] Available from: https://observatorio.fm.usp.br/handle/OPI/53836
Vancouver
Jorgetti V, Barros PDS, Shinjo SK, Bonfa ESD de O. Rosa Maria Rodrigues Pereira (1958-2022) IN MEMORIAM [Internet]. Journal of bone and mineral research. 2023 ; 38( 3): 357-358.[citado 2024 jun. 29 ] Available from: https://observatorio.fm.usp.br/handle/OPI/53836
Artigo de periodico
No Associations Between Physical Activity and Immunogenicity in SARS-CoV-2 Seropositive Patients With Autoimmune Rheumatic Diseases Prior to and After Vaccination (2023)
Smaira, Fabiana Infante ; Mazzolani, Bruna Caruso ; Lemes, Ítalo Ribeiro ; Silva, Rafael Pires da ; Pinto, Ana J ; Sieczkowska, Sofia M ; Aikawa, Nadia E ; Pasoto, Sandra G ; Medeiros-Ribeiro, Ana C ; Saad, Carla G. S ; Yuki, Emily F. N ; Silva, Clovis A ; Swinton, Paul ; Kupa, Leonard de Vinci Kanda ; Hallal, Pedro Curi ; Roschel, Hamilton ; Gualano, Bruno ; Bonfa, Eloisa Silva Dutra de Oliveira
Source: Journal of Physical Activity and Health. Unidades: FM, EEFE
Subjects: COVID-19, ATIVIDADE FÍSICA, VACINAS, IMUNOSSUPRESSÃO, DOENÇAS REUMÁTICAS, ESTUDOS DE COORTES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SMAIRA, Fabiana Infante et al. No Associations Between Physical Activity and Immunogenicity in SARS-CoV-2 Seropositive Patients With Autoimmune Rheumatic Diseases Prior to and After Vaccination. Journal of Physical Activity and Health, v. 20, n. 10, p. 980-983, 2023Tradução . . Disponível em: https://doi.org/10.1123/jpah.2022-0362. Acesso em: 29 jun. 2024.
APA
Smaira, F. I., Mazzolani, B. C., Lemes, Í. R., Silva, R. P. da, Pinto, A. J., Sieczkowska, S. M., et al. (2023). No Associations Between Physical Activity and Immunogenicity in SARS-CoV-2 Seropositive Patients With Autoimmune Rheumatic Diseases Prior to and After Vaccination. Journal of Physical Activity and Health, 20( 10), 980-983. doi:10.1123/jpah.2022-0362
NLM
Smaira FI, Mazzolani BC, Lemes ÍR, Silva RP da, Pinto AJ, Sieczkowska SM, Aikawa NE, Pasoto SG, Medeiros-Ribeiro AC, Saad CGS, Yuki EFN, Silva CA, Swinton P, Kupa L de VK, Hallal PC, Roschel H, Gualano B, Bonfa ESD de O. No Associations Between Physical Activity and Immunogenicity in SARS-CoV-2 Seropositive Patients With Autoimmune Rheumatic Diseases Prior to and After Vaccination [Internet]. Journal of Physical Activity and Health. 2023 ; 20( 10): 980-983.[citado 2024 jun. 29 ] Available from: https://doi.org/10.1123/jpah.2022-0362
Vancouver
Smaira FI, Mazzolani BC, Lemes ÍR, Silva RP da, Pinto AJ, Sieczkowska SM, Aikawa NE, Pasoto SG, Medeiros-Ribeiro AC, Saad CGS, Yuki EFN, Silva CA, Swinton P, Kupa L de VK, Hallal PC, Roschel H, Gualano B, Bonfa ESD de O. No Associations Between Physical Activity and Immunogenicity in SARS-CoV-2 Seropositive Patients With Autoimmune Rheumatic Diseases Prior to and After Vaccination [Internet]. Journal of Physical Activity and Health. 2023 ; 20( 10): 980-983.[citado 2024 jun. 29 ] Available from: https://doi.org/10.1123/jpah.2022-0362
Artigo de periodico
Anti-SARS-CoV-2 inactivated vaccine in patients with ANCA-associated vasculitis: Immunogenicity, safety, antibody decay and the booster dose (2023)
Pereira, Rosa Maria Rodrigues; Dagostin, Marilia A.; Caparbo, Valeria F.; Sales, Lucas P.; Pasoto, Sandra G.; Silva, Clovis A.; Yuki, Emily F. N.; Saad, Carla G. S.; SHINJO, Samuel K.; BONFA, Eloisa
Source: Clinics. Unidade: FM
Subjects: IMUNOGENÉTICA, COVID-19, VACINAS VIRAIS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PEREIRA, Rosa Maria Rodrigues et al. Anti-SARS-CoV-2 inactivated vaccine in patients with ANCA-associated vasculitis: Immunogenicity, safety, antibody decay and the booster dose. Clinics, v. 78, 2023Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/52881. Acesso em: 29 jun. 2024.
APA
Pereira, R. M. R., Dagostin, M. A., Caparbo, V. F., Sales, L. P., Pasoto, S. G., Silva, C. A., et al. (2023). Anti-SARS-CoV-2 inactivated vaccine in patients with ANCA-associated vasculitis: Immunogenicity, safety, antibody decay and the booster dose. Clinics, 78. doi:10.1016/j.clinsp.2022.100150
NLM
Pereira RMR, Dagostin MA, Caparbo VF, Sales LP, Pasoto SG, Silva CA, Yuki EFN, Saad CGS, SHINJO SK, BONFA E. Anti-SARS-CoV-2 inactivated vaccine in patients with ANCA-associated vasculitis: Immunogenicity, safety, antibody decay and the booster dose [Internet]. Clinics. 2023 ; 78[citado 2024 jun. 29 ] Available from: https://observatorio.fm.usp.br/handle/OPI/52881
Vancouver
Pereira RMR, Dagostin MA, Caparbo VF, Sales LP, Pasoto SG, Silva CA, Yuki EFN, Saad CGS, SHINJO SK, BONFA E. Anti-SARS-CoV-2 inactivated vaccine in patients with ANCA-associated vasculitis: Immunogenicity, safety, antibody decay and the booster dose [Internet]. Clinics. 2023 ; 78[citado 2024 jun. 29 ] Available from: https://observatorio.fm.usp.br/handle/OPI/52881
Artigo de periodico-carta/editorial
Challenges in Managing a Medical School. [Editorial] (2023)
Fernandes, Paulo Manuel Pego ; Bonfa, Eloisa Silva Dutra de Oliveira
Source: Sao paulo medical journal. Unidade: FM
Subjects: ARTIGOS DE PERIÓDICOS, ACESSO À INFORMAÇÃO PÚBLICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FERNANDES, Paulo Manuel Pego e BONFA, Eloisa Silva Dutra de Oliveira. Challenges in Managing a Medical School. [Editorial]. Sao paulo medical journal. Sao Paulo: Faculdade de Medicina, Universidade de São Paulo. Disponível em: https://observatorio.fm.usp.br/handle/OPI/53861. Acesso em: 29 jun. 2024. , 2023
APA
Fernandes, P. M. P., & Bonfa, E. S. D. de O. (2023). Challenges in Managing a Medical School. [Editorial]. Sao paulo medical journal. Sao Paulo: Faculdade de Medicina, Universidade de São Paulo. doi:10.1590/1516-3180.2022.141216122022
NLM
Fernandes PMP, Bonfa ESD de O. Challenges in Managing a Medical School. [Editorial] [Internet]. Sao paulo medical journal. 2023 ; 141( 2): 87-88.[citado 2024 jun. 29 ] Available from: https://observatorio.fm.usp.br/handle/OPI/53861
Vancouver
Fernandes PMP, Bonfa ESD de O. Challenges in Managing a Medical School. [Editorial] [Internet]. Sao paulo medical journal. 2023 ; 141( 2): 87-88.[citado 2024 jun. 29 ] Available from: https://observatorio.fm.usp.br/handle/OPI/53861
Artigo de periodico
Short-term Accrual 2019 European League Against Rheumatism/American College of Rheumatology Domains and Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage in Lupus Patients With and Without Nephritis at Disease Onset (2023)
Munhoz, Gabriela A; Aikawa, Nadia E; Silva, Clovis Artur Almeida da ; Pasoto, Sandra G; Pedrosa, Tatiana N; Seguro, Luciana P. C; Bonfa, Eloisa Silva Dutra de Oliveira ; Borba Neto, Eduardo Ferreira
Source: Jcr-journal of clinical rheumatology. Unidade: FM
Subjects: NEFRITE, LÚPUS ERITEMATOSO SISTÊMICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MUNHOZ, Gabriela A et al. Short-term Accrual 2019 European League Against Rheumatism/American College of Rheumatology Domains and Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage in Lupus Patients With and Without Nephritis at Disease Onset. Jcr-journal of clinical rheumatology, v. 29, n. 4, p. 190-195, 2023Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/53986. Acesso em: 29 jun. 2024.
APA
Munhoz, G. A., Aikawa, N. E., Silva, C. A. A. da, Pasoto, S. G., Pedrosa, T. N., Seguro, L. P. C., et al. (2023). Short-term Accrual 2019 European League Against Rheumatism/American College of Rheumatology Domains and Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage in Lupus Patients With and Without Nephritis at Disease Onset. Jcr-journal of clinical rheumatology, 29( 4), 190-195. doi:10.1097/RHU.0000000000001939
NLM
Munhoz GA, Aikawa NE, Silva CAA da, Pasoto SG, Pedrosa TN, Seguro LPC, Bonfa ESD de O, Borba Neto EF. Short-term Accrual 2019 European League Against Rheumatism/American College of Rheumatology Domains and Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage in Lupus Patients With and Without Nephritis at Disease Onset [Internet]. Jcr-journal of clinical rheumatology. 2023 ; 29( 4): 190-195.[citado 2024 jun. 29 ] Available from: https://observatorio.fm.usp.br/handle/OPI/53986
Vancouver
Munhoz GA, Aikawa NE, Silva CAA da, Pasoto SG, Pedrosa TN, Seguro LPC, Bonfa ESD de O, Borba Neto EF. Short-term Accrual 2019 European League Against Rheumatism/American College of Rheumatology Domains and Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage in Lupus Patients With and Without Nephritis at Disease Onset [Internet]. Jcr-journal of clinical rheumatology. 2023 ; 29( 4): 190-195.[citado 2024 jun. 29 ] Available from: https://observatorio.fm.usp.br/handle/OPI/53986
Artigo de periodico
Safety and immunogenicity of influenza A(H3N2) component vaccine in juvenile systemic lupus erythematosus (2023)
Aikawa, Nadia Emi ; Borba Neto, Eduardo Ferreira ; Balbi, Verena Andrade ; Sallum, Adriana Maluf Elias ; Buscatti, Izabel Mantovani ; Campos, Lúcia Maria Mattei de Arruda; Kozu, Katia Tomie ; Garcia, Cristiana Couto; Capao, Artur Silva Vidal ; Proença, Adriana Coracini Tonacio de ; Leon, Elaine Pires ; Duarte, Alberto José da Silva ; Lopes, Marta Heloísa ; Silva, Clovis Artur Almeida da ; Bonfa, Eloisa Silva Dutra de Oliveira
Source: Advances in rheumatology. Unidade: FM
Subjects: LÚPUS ERITEMATOSO SISTÊMICO, VACINAS VIRAIS, INFLUENZA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
AIKAWA, Nadia Emi et al. Safety and immunogenicity of influenza A(H3N2) component vaccine in juvenile systemic lupus erythematosus. Advances in rheumatology, v. 63, n. 1, 2023Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/57309. Acesso em: 29 jun. 2024.
APA
Aikawa, N. E., Borba Neto, E. F., Balbi, V. A., Sallum, A. M. E., Buscatti, I. M., Campos, L. M. M. de A., et al. (2023). Safety and immunogenicity of influenza A(H3N2) component vaccine in juvenile systemic lupus erythematosus. Advances in rheumatology, 63( 1). doi:10.1186/s42358-023-00339-7
NLM
Aikawa NE, Borba Neto EF, Balbi VA, Sallum AME, Buscatti IM, Campos LMM de A, Kozu KT, Garcia CC, Capao ASV, Proença ACT de, Leon EP, Duarte AJ da S, Lopes MH, Silva CAA da, Bonfa ESD de O. Safety and immunogenicity of influenza A(H3N2) component vaccine in juvenile systemic lupus erythematosus [Internet]. Advances in rheumatology. 2023 ; 63( 1):[citado 2024 jun. 29 ] Available from: https://observatorio.fm.usp.br/handle/OPI/57309
Vancouver
Aikawa NE, Borba Neto EF, Balbi VA, Sallum AME, Buscatti IM, Campos LMM de A, Kozu KT, Garcia CC, Capao ASV, Proença ACT de, Leon EP, Duarte AJ da S, Lopes MH, Silva CAA da, Bonfa ESD de O. Safety and immunogenicity of influenza A(H3N2) component vaccine in juvenile systemic lupus erythematosus [Internet]. Advances in rheumatology. 2023 ; 63( 1):[citado 2024 jun. 29 ] Available from: https://observatorio.fm.usp.br/handle/OPI/57309
Parte de monografia/livro-apres/pref/posf
Apresentamos a nova edição do estudo Demografia Médica no Brasil, conduzido pelo Depertamento de Medicina Preventiva da Faculdade de Medidina da Universidade de São Paulo (FMUSP).[Apresentação] (2023)
Bonfa, Eloisa Silva Dutra de Oliveira
Source: Demgrafia médica no Brasil 2023. Unidade: FM
Subjects: MEDICINA, ESPECIALIDADES MÉDICAS, DEMOGRAFIA EM SAÚDE PÚBLICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BONFA, Eloisa Silva Dutra de Oliveira. Apresentamos a nova edição do estudo Demografia Médica no Brasil, conduzido pelo Depertamento de Medicina Preventiva da Faculdade de Medidina da Universidade de São Paulo (FMUSP).[Apresentação]. Demgrafia médica no Brasil 2023. São Paulo: FMSUP. . Acesso em: 29 jun. 2024. , 2023
APA
Bonfa, E. S. D. de O. (2023). Apresentamos a nova edição do estudo Demografia Médica no Brasil, conduzido pelo Depertamento de Medicina Preventiva da Faculdade de Medidina da Universidade de São Paulo (FMUSP).[Apresentação]. Demgrafia médica no Brasil 2023. São Paulo: FMSUP.
NLM
Bonfa ESD de O. Apresentamos a nova edição do estudo Demografia Médica no Brasil, conduzido pelo Depertamento de Medicina Preventiva da Faculdade de Medidina da Universidade de São Paulo (FMUSP).[Apresentação]. Demgrafia médica no Brasil 2023. 2023 ;[citado 2024 jun. 29 ]
Vancouver
Bonfa ESD de O. Apresentamos a nova edição do estudo Demografia Médica no Brasil, conduzido pelo Depertamento de Medicina Preventiva da Faculdade de Medidina da Universidade de São Paulo (FMUSP).[Apresentação]. Demgrafia médica no Brasil 2023. 2023 ;[citado 2024 jun. 29 ]
Artigo de periodico
Physical Activity: A Strategy to Improve Antibody Response to a SARS-CoV-2 Vaccine Booster Dose in Patients With Autoimmune Rheumatic Diseases (2023)
Gualano, Bruno ; Sieczkowska, Sofia M ; Lemes, Ítalo Ribeiro ; Silva, Rafael Pires da ; Pinto, Ana Jéssica ; Mazzolani, Bruna C ; Smaira, Fabiana I ; Aikawa, Nadia E ; Kupa, Leonard de V K ; Pasoto, Sandra G ; Medeiros-Ribeiro, Ana C ; Saad, Carla G. S ; Yuk, Emily F. N; Silva, Clovis A ; Swinton, Paul ; Hallal, Pedro Curi ; Roschel, Hamilton ; Bonfa, Eloisa Silva Dutra de Oliveira
Source: Journal of Physical Activity and Health. Unidades: FM, EEFE
Subjects: COVID-19, SEDENTARISMO, VACINAS, IMUNOSSUPRESSÃO, DOENÇAS AUTOIMUNES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GUALANO, Bruno et al. Physical Activity: A Strategy to Improve Antibody Response to a SARS-CoV-2 Vaccine Booster Dose in Patients With Autoimmune Rheumatic Diseases. Journal of Physical Activity and Health, v. 20, n. 4, p. 311-316, 2023Tradução . . Disponível em: https://doi.org/10.1123/jpah.2022-0332. Acesso em: 29 jun. 2024.
APA
Gualano, B., Sieczkowska, S. M., Lemes, Í. R., Silva, R. P. da, Pinto, A. J., Mazzolani, B. C., et al. (2023). Physical Activity: A Strategy to Improve Antibody Response to a SARS-CoV-2 Vaccine Booster Dose in Patients With Autoimmune Rheumatic Diseases. Journal of Physical Activity and Health, 20( 4), 311-316. doi:10.1123/jpah.2022-0332
NLM
Gualano B, Sieczkowska SM, Lemes ÍR, Silva RP da, Pinto AJ, Mazzolani BC, Smaira FI, Aikawa NE, Kupa L de VK, Pasoto SG, Medeiros-Ribeiro AC, Saad CGS, Yuk EFN, Silva CA, Swinton P, Hallal PC, Roschel H, Bonfa ESD de O. Physical Activity: A Strategy to Improve Antibody Response to a SARS-CoV-2 Vaccine Booster Dose in Patients With Autoimmune Rheumatic Diseases [Internet]. Journal of Physical Activity and Health. 2023 ; 20( 4): 311-316.[citado 2024 jun. 29 ] Available from: https://doi.org/10.1123/jpah.2022-0332
Vancouver
Gualano B, Sieczkowska SM, Lemes ÍR, Silva RP da, Pinto AJ, Mazzolani BC, Smaira FI, Aikawa NE, Kupa L de VK, Pasoto SG, Medeiros-Ribeiro AC, Saad CGS, Yuk EFN, Silva CA, Swinton P, Hallal PC, Roschel H, Bonfa ESD de O. Physical Activity: A Strategy to Improve Antibody Response to a SARS-CoV-2 Vaccine Booster Dose in Patients With Autoimmune Rheumatic Diseases [Internet]. Journal of Physical Activity and Health. 2023 ; 20( 4): 311-316.[citado 2024 jun. 29 ] Available from: https://doi.org/10.1123/jpah.2022-0332
Artigo de periodico
In Memoriam - Rosa Maria Rodrigues Pereira (1958-2022) (2022)
Bonfa, Eloisa Silva Dutra de Oliveira ; Sampaio-Barros, Percival
Source: Advances in rheumatology. Unidade: FM
Subjects: REUMATOLOGIA, BIOGRAFIAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BONFA, Eloisa Silva Dutra de Oliveira e SAMPAIO-BARROS, Percival. In Memoriam - Rosa Maria Rodrigues Pereira (1958-2022). Advances in rheumatology, v. 62, n. 1, 2022Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/50377. Acesso em: 29 jun. 2024.
APA
Bonfa, E. S. D. de O., & Sampaio-Barros, P. (2022). In Memoriam - Rosa Maria Rodrigues Pereira (1958-2022). Advances in rheumatology, 62( 1). doi:10.1186/s42358-022-00272-1
NLM
Bonfa ESD de O, Sampaio-Barros P. In Memoriam - Rosa Maria Rodrigues Pereira (1958-2022) [Internet]. Advances in rheumatology. 2022 ; 62( 1):[citado 2024 jun. 29 ] Available from: https://observatorio.fm.usp.br/handle/OPI/50377
Vancouver
Bonfa ESD de O, Sampaio-Barros P. In Memoriam - Rosa Maria Rodrigues Pereira (1958-2022) [Internet]. Advances in rheumatology. 2022 ; 62( 1):[citado 2024 jun. 29 ] Available from: https://observatorio.fm.usp.br/handle/OPI/50377
Artigo de periodico
Controversies in Systemic Lupus Erythematosus Are We Treating Our Patients Adequately? (2022)
Porta, Sabrina Valeria; Ugarte-Gil, Manuel F; Torre, Ignacio Garcia-de la; Bonfa, Eloisa Silva Dutra de Oliveira ; Gomez-Puerta, Jose A; Arnaud, Laurent; Cardiel, Mario H; Alarcon, Graciela S; Pons-Estel, Bernardo A; Pons-Estel, Guillermo
Source: Jcr-journal of clinical rheumatology. Unidade: FM
Subjects: SUBSTÂNCIAS TÓXICAS, LÚPUS ERITEMATOSO SISTÊMICO, NEFRITE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PORTA, Sabrina Valeria et al. Controversies in Systemic Lupus Erythematosus Are We Treating Our Patients Adequately?. Jcr-journal of clinical rheumatology, v. 28, n. 2, p. E651-E658, 2022Tradução . . Disponível em: https://doi.org/10.1097/RHU.0000000000001803. Acesso em: 29 jun. 2024.
APA
Porta, S. V., Ugarte-Gil, M. F., Torre, I. G. -de la, Bonfa, E. S. D. de O., Gomez-Puerta, J. A., Arnaud, L., et al. (2022). Controversies in Systemic Lupus Erythematosus Are We Treating Our Patients Adequately? Jcr-journal of clinical rheumatology, 28( 2), E651-E658. doi:10.1097/RHU.0000000000001803
NLM
Porta SV, Ugarte-Gil MF, Torre IG-de la, Bonfa ESD de O, Gomez-Puerta JA, Arnaud L, Cardiel MH, Alarcon GS, Pons-Estel BA, Pons-Estel G. Controversies in Systemic Lupus Erythematosus Are We Treating Our Patients Adequately? [Internet]. Jcr-journal of clinical rheumatology. 2022 ; 28( 2): E651-E658.[citado 2024 jun. 29 ] Available from: https://doi.org/10.1097/RHU.0000000000001803
Vancouver
Porta SV, Ugarte-Gil MF, Torre IG-de la, Bonfa ESD de O, Gomez-Puerta JA, Arnaud L, Cardiel MH, Alarcon GS, Pons-Estel BA, Pons-Estel G. Controversies in Systemic Lupus Erythematosus Are We Treating Our Patients Adequately? [Internet]. Jcr-journal of clinical rheumatology. 2022 ; 28( 2): E651-E658.[citado 2024 jun. 29 ] Available from: https://doi.org/10.1097/RHU.0000000000001803
Artigo de periodico
2019-EULAR/ACR classification criteria domains at diagnosis: predictive factors of long-term damage in systemic lupus erythematosus (2022)
Insfran, Carlos E; Aikawa, Nadia E; Pasoto, Sandra G; Filho, Dilson M. N; Formiga, Francisco F. C; Pitta, Ana C; Borba Neto, Eduardo Ferreira ; Ribeiro, Carolina T; Silva, Clovis Artur Almeida da ; Bonfa, Eloisa Silva Dutra de Oliveira
Source: Clinical rheumatology. Unidade: FM
Subjects: LÚPUS ERITEMATOSO SISTÊMICO, MULHERES 2LARPCAL, NEFROPATIAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
INSFRAN, Carlos E et al. 2019-EULAR/ACR classification criteria domains at diagnosis: predictive factors of long-term damage in systemic lupus erythematosus. Clinical rheumatology, v. 41, n. 4, p. 1079-1085, 2022Tradução . . Disponível em: https://doi.org/10.1007/s10067-021-05989-w. Acesso em: 29 jun. 2024.
APA
Insfran, C. E., Aikawa, N. E., Pasoto, S. G., Filho, D. M. N., Formiga, F. F. C., Pitta, A. C., et al. (2022). 2019-EULAR/ACR classification criteria domains at diagnosis: predictive factors of long-term damage in systemic lupus erythematosus. Clinical rheumatology, 41( 4), 1079-1085. doi:10.1007/s10067-021-05989-w
NLM
Insfran CE, Aikawa NE, Pasoto SG, Filho DMN, Formiga FFC, Pitta AC, Borba Neto EF, Ribeiro CT, Silva CAA da, Bonfa ESD de O. 2019-EULAR/ACR classification criteria domains at diagnosis: predictive factors of long-term damage in systemic lupus erythematosus [Internet]. Clinical rheumatology. 2022 ; 41( 4): 1079-1085.[citado 2024 jun. 29 ] Available from: https://doi.org/10.1007/s10067-021-05989-w
Vancouver
Insfran CE, Aikawa NE, Pasoto SG, Filho DMN, Formiga FFC, Pitta AC, Borba Neto EF, Ribeiro CT, Silva CAA da, Bonfa ESD de O. 2019-EULAR/ACR classification criteria domains at diagnosis: predictive factors of long-term damage in systemic lupus erythematosus [Internet]. Clinical rheumatology. 2022 ; 41( 4): 1079-1085.[citado 2024 jun. 29 ] Available from: https://doi.org/10.1007/s10067-021-05989-w
Artigo de periodico
Gathering patients and rheumatologists' perceptions to improve outcomes in idiopathic inflammatory myopathies (2022)
Bertoglio, Isabela M; Abrahao, Glaucia F; Souza, Fernando H. C. de; Miossi, Renata; Moraes, Paloma C. de; Shinjo, Samuel Katsuyuki ; Bonfa, Eloisa Silva Dutra de Oliveira ; Lopes, Michelle R. Ugolini
Source: Clinics. Unidade: FM
Subjects: DOENÇAS NEURODEGENERATIVAS, PERCEPÇÃO DE DOR, INFLAMAÇÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BERTOGLIO, Isabela M et al. Gathering patients and rheumatologists' perceptions to improve outcomes in idiopathic inflammatory myopathies. Clinics, v. 77, 2022Tradução . . Disponível em: https://doi.org/10.1016/j.clinsp.2022.100031. Acesso em: 29 jun. 2024.
APA
Bertoglio, I. M., Abrahao, G. F., Souza, F. H. C. de, Miossi, R., Moraes, P. C. de, Shinjo, S. K., et al. (2022). Gathering patients and rheumatologists' perceptions to improve outcomes in idiopathic inflammatory myopathies. Clinics, 77. doi:10.1016/j.clinsp.2022.100031
NLM
Bertoglio IM, Abrahao GF, Souza FHC de, Miossi R, Moraes PC de, Shinjo SK, Bonfa ESD de O, Lopes MRU. Gathering patients and rheumatologists' perceptions to improve outcomes in idiopathic inflammatory myopathies [Internet]. Clinics. 2022 ; 77[citado 2024 jun. 29 ] Available from: https://doi.org/10.1016/j.clinsp.2022.100031
Vancouver
Bertoglio IM, Abrahao GF, Souza FHC de, Miossi R, Moraes PC de, Shinjo SK, Bonfa ESD de O, Lopes MRU. Gathering patients and rheumatologists' perceptions to improve outcomes in idiopathic inflammatory myopathies [Internet]. Clinics. 2022 ; 77[citado 2024 jun. 29 ] Available from: https://doi.org/10.1016/j.clinsp.2022.100031
Artigo de periodico
Impact of distinct therapies on antibody response to SARS-CoV-2 vaccine in systemic lupus erythematosus (2022)
Yuki, Emily F. N; Borba Neto, Eduardo Ferreira ; Pasoto, Sandra G; Seguro, Luciana P; Lopes, Michelle; Saad, Carla G. S; Silva, Clovis Artur Almeida da ; Kupa, Leonard de Vinci Kanda ; Kallas, Esper Georges ; Bonfa, Eloisa Silva Dutra de Oliveira
Source: Arthritis care & research. Unidade: FM
Subjects: ANTICORPOS, VACINAS VIRAIS, COVID-19
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
YUKI, Emily F. N et al. Impact of distinct therapies on antibody response to SARS-CoV-2 vaccine in systemic lupus erythematosus. Arthritis care & research, v. 74, n. 4, p. 562-571, 2022Tradução . . Disponível em: https://doi.org/10.1002/acr.24824. Acesso em: 29 jun. 2024.
APA
Yuki, E. F. N., Borba Neto, E. F., Pasoto, S. G., Seguro, L. P., Lopes, M., Saad, C. G. S., et al. (2022). Impact of distinct therapies on antibody response to SARS-CoV-2 vaccine in systemic lupus erythematosus. Arthritis care & research, 74( 4), 562-571. doi:10.1002/acr.24824
NLM
Yuki EFN, Borba Neto EF, Pasoto SG, Seguro LP, Lopes M, Saad CGS, Silva CAA da, Kupa L de VK, Kallas EG, Bonfa ESD de O. Impact of distinct therapies on antibody response to SARS-CoV-2 vaccine in systemic lupus erythematosus [Internet]. Arthritis care & research. 2022 ; 74( 4): 562-571.[citado 2024 jun. 29 ] Available from: https://doi.org/10.1002/acr.24824
Vancouver
Yuki EFN, Borba Neto EF, Pasoto SG, Seguro LP, Lopes M, Saad CGS, Silva CAA da, Kupa L de VK, Kallas EG, Bonfa ESD de O. Impact of distinct therapies on antibody response to SARS-CoV-2 vaccine in systemic lupus erythematosus [Internet]. Arthritis care & research. 2022 ; 74( 4): 562-571.[citado 2024 jun. 29 ] Available from: https://doi.org/10.1002/acr.24824
Artigo de periodico
Two-week methotrexate discontinuation in patients with rheumatoid arthritis vaccinated with inactivated SARS-CoV-2 vaccine: a randomised clinical trial (2022)
Araujo, Carlo Scognamiglio Renner; Medeiros-Ribeiro, Ana Cristina; Saad, Carla G. S; Bonfiglioli, Karina Rossi; Domiciano, Diogo Souza; Shimabuco, Andrea Yukie; Kupa, Leonard de Vinci Kanda ; Pereira, Rosa Maria Rodrigues ; Silva, Clovis Artur Almeida da ; Bonfa, Eloisa Silva Dutra de Oliveira
Source: Annals of the rheumatic diseases. Unidade: FM
Subjects: METOTREXATO, VACINAS VIRAIS, ARTRITE REUMATOIDE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ARAUJO, Carlo Scognamiglio Renner et al. Two-week methotrexate discontinuation in patients with rheumatoid arthritis vaccinated with inactivated SARS-CoV-2 vaccine: a randomised clinical trial. Annals of the rheumatic diseases, v. 81, n. 6, p. 889-897, 2022Tradução . . Disponível em: https://doi.org/10.1136/annrheumdis-2021-221916. Acesso em: 29 jun. 2024.
APA
Araujo, C. S. R., Medeiros-Ribeiro, A. C., Saad, C. G. S., Bonfiglioli, K. R., Domiciano, D. S., Shimabuco, A. Y., et al. (2022). Two-week methotrexate discontinuation in patients with rheumatoid arthritis vaccinated with inactivated SARS-CoV-2 vaccine: a randomised clinical trial. Annals of the rheumatic diseases, 81( 6), 889-897. doi:10.1136/annrheumdis-2021-221916
NLM
Araujo CSR, Medeiros-Ribeiro AC, Saad CGS, Bonfiglioli KR, Domiciano DS, Shimabuco AY, Kupa L de VK, Pereira RMR, Silva CAA da, Bonfa ESD de O. Two-week methotrexate discontinuation in patients with rheumatoid arthritis vaccinated with inactivated SARS-CoV-2 vaccine: a randomised clinical trial [Internet]. Annals of the rheumatic diseases. 2022 ; 81( 6): 889-897.[citado 2024 jun. 29 ] Available from: https://doi.org/10.1136/annrheumdis-2021-221916
Vancouver
Araujo CSR, Medeiros-Ribeiro AC, Saad CGS, Bonfiglioli KR, Domiciano DS, Shimabuco AY, Kupa L de VK, Pereira RMR, Silva CAA da, Bonfa ESD de O. Two-week methotrexate discontinuation in patients with rheumatoid arthritis vaccinated with inactivated SARS-CoV-2 vaccine: a randomised clinical trial [Internet]. Annals of the rheumatic diseases. 2022 ; 81( 6): 889-897.[citado 2024 jun. 29 ] Available from: https://doi.org/10.1136/annrheumdis-2021-221916
Artigo de periodico-carta/editorial
Palliative care in the COVID-19 pandemic.[Carta]: strategy of HCFMUSP (2022)
Carvalho, Ricardo Tavares de; Crispim, Douglas Henrique; Franck, Ednalda Maria; Santi, Daniel Battacini Dei; Anagusko, Sergio Seiki; Fukuda, Marcio Veronesi; Cavalcante, Luciana Suelly Barros; Jales, Sumatra Melo da Costa Pereira; Queiroz, Monica Estuque Garcia de; Bonfa, Eloisa Silva Dutra de Oliveira
Source: Clinics. Unidade: FM
Subjects: COVID-19, CUIDADOS PALIATIVOS, ESTRATÉGIAS TERAPÊUTICAS, HOSPITAIS DE ENSINO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CARVALHO, Ricardo Tavares de et al. Palliative care in the COVID-19 pandemic.[Carta]: strategy of HCFMUSP. Clinics. Madrid: Faculdade de Medicina, Universidade de São Paulo. Disponível em: https://doi.org/10.1016/j.clinsp.2022.100050. Acesso em: 29 jun. 2024. , 2022
APA
Carvalho, R. T. de, Crispim, D. H., Franck, E. M., Santi, D. B. D., Anagusko, S. S., Fukuda, M. V., et al. (2022). Palliative care in the COVID-19 pandemic.[Carta]: strategy of HCFMUSP. Clinics. Madrid: Faculdade de Medicina, Universidade de São Paulo. doi:10.1016/j.clinsp.2022.100050
NLM
Carvalho RT de, Crispim DH, Franck EM, Santi DBD, Anagusko SS, Fukuda MV, Cavalcante LSB, Jales SM da CP, Queiroz MEG de, Bonfa ESD de O. Palliative care in the COVID-19 pandemic.[Carta]: strategy of HCFMUSP [Internet]. Clinics. 2022 ; 77[citado 2024 jun. 29 ] Available from: https://doi.org/10.1016/j.clinsp.2022.100050
Vancouver
Carvalho RT de, Crispim DH, Franck EM, Santi DBD, Anagusko SS, Fukuda MV, Cavalcante LSB, Jales SM da CP, Queiroz MEG de, Bonfa ESD de O. Palliative care in the COVID-19 pandemic.[Carta]: strategy of HCFMUSP [Internet]. Clinics. 2022 ; 77[citado 2024 jun. 29 ] Available from: https://doi.org/10.1016/j.clinsp.2022.100050
Artigo de periodico
Distinct impact of DMARD combination and monotherapy in immunogenicity of an inactivated SARS-CoV-2 vaccine in rheumatoid arthritis (2022)
Medeiros-Ribeiro, Ana Cristina; Bonfiglioli, Karina Rossi; Domiciano, Diogo Souza; Shimabuco, Andrea Yukie; Silva, Henrique Carrico da; Saad, Carla G. S.; Yuki, Emily Figueiredo Neves; Pasoto, Sandra Gofinet; Araujo, Carlo Scognamiglio Renner; Nakai, Tatiane Lie; Silva, Clovis Artur Almeida da ; Kupa, Leonard de Vinci Kanda ; Kallas, Esper Georges ; Bonfa, Eloisa Silva Dutra de Oliveira
Source: Annals of the rheumatic diseases. Unidade: FM
Subjects: FÁRMACOS DO SANGUE E SISTEMA HEMATOPOÉTICO, ESTUDOS PROSPECTIVOS, SISTEMA IMUNE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MEDEIROS-RIBEIRO, Ana Cristina et al. Distinct impact of DMARD combination and monotherapy in immunogenicity of an inactivated SARS-CoV-2 vaccine in rheumatoid arthritis. Annals of the rheumatic diseases, v. 81, n. 5, p. 710-719, 2022Tradução . . Disponível em: https://doi.org/10.1136/annrheumdis-2021-221735. Acesso em: 29 jun. 2024.
APA
Medeiros-Ribeiro, A. C., Bonfiglioli, K. R., Domiciano, D. S., Shimabuco, A. Y., Silva, H. C. da, Saad, C. G. S., et al. (2022). Distinct impact of DMARD combination and monotherapy in immunogenicity of an inactivated SARS-CoV-2 vaccine in rheumatoid arthritis. Annals of the rheumatic diseases, 81( 5), 710-719. doi:10.1136/annrheumdis-2021-221735
NLM
Medeiros-Ribeiro AC, Bonfiglioli KR, Domiciano DS, Shimabuco AY, Silva HC da, Saad CGS, Yuki EFN, Pasoto SG, Araujo CSR, Nakai TL, Silva CAA da, Kupa L de VK, Kallas EG, Bonfa ESD de O. Distinct impact of DMARD combination and monotherapy in immunogenicity of an inactivated SARS-CoV-2 vaccine in rheumatoid arthritis [Internet]. Annals of the rheumatic diseases. 2022 ; 81( 5): 710-719.[citado 2024 jun. 29 ] Available from: https://doi.org/10.1136/annrheumdis-2021-221735
Vancouver
Medeiros-Ribeiro AC, Bonfiglioli KR, Domiciano DS, Shimabuco AY, Silva HC da, Saad CGS, Yuki EFN, Pasoto SG, Araujo CSR, Nakai TL, Silva CAA da, Kupa L de VK, Kallas EG, Bonfa ESD de O. Distinct impact of DMARD combination and monotherapy in immunogenicity of an inactivated SARS-CoV-2 vaccine in rheumatoid arthritis [Internet]. Annals of the rheumatic diseases. 2022 ; 81( 5): 710-719.[citado 2024 jun. 29 ] Available from: https://doi.org/10.1136/annrheumdis-2021-221735

USP Schools

ReP

Filtros

Document Types

USP Schools

Departament

Authors

USP affiliated authors

Date published

Subjects

Source title

Publisher

Conference titles

Countries/Territories

Funding Agencies

Indexado em

Normalized affiliation

Non normalized affiliation